Former British Columbia Premier Christy Clark said Canopy Growth (NYSE:CGC,TSX:WEED) is the “best positioned of all the companies” in the highly regulated cannabis sector.

Constellation Brands (NYSE:STZ), one of Canopy Growth’s biggest partners, confirmed Clark’s appointment to its board of directors in September, alongside Jose Manuel Madero, citing Clark’s “extensive knowledge” of Canada’s regulatory and political environment as benefits.

Clark sat as the provincial premier from 2011 to 2017 after working as both the minister of education and minister of children and family development in British Columbia.

In an interview with BNN Bloomberg on Friday (October 4), the former politician spoke about her excitement at joining the ranks at Constellation, a company she said is skilled at delivering on products in highly regulated industries.

Clark noted that the fledgling regulatory environment of the marijuana market won’t be well served by having a lot of smaller companies selling cannabis, but said Canopy Growth and Constellation have the capability to make the safe creation and distribution of cannabis products possible.

“There aren’t really any other companies in the cannabis space at the moment that have this level of capacity,” she said.

The former British Columbia premier isn’t the only player in the cannabis space with a political past. Former Canadian Prime Minister Brian Mulroney and former Speaker of the House John Boehner have both backed cannabis company Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF), another firm with a Canopy Growth deal.

Clark added that there is “huge potential on the (intellectual property) side” when it comes to the nascent industry, and said that further research on the medicinal applications of marijuana will be the biggest driver of growth. It is a space, she said, that Constellation will dominate.

The American beer maker pumped C$5 billion into Canopy last year to assist in branding, intellectual property and retailing for the cannabis company.

Clark’s addition to Constellation’s roster was another big management move for the company after former Canopy CEO Bruce Linton was pushed out of his role as chief executive.

With the investment, a conditional board reconfigurement was set, and that same board, largely composed of Constellation executives, terminated Linton after being unimpressed by some less-than-stellar quarterly results.

Shares of Constellation took a hit last week after it released its results for Q2 2020 on Thursday (October 3). The company reported a loss of US$484.4 million from its stake in Canopy Growth.

Constellation also reported a US$757 million unrealized net gain in reported basis results since its initial C$245 million investment into Canopy in 2017. A US$839 million decrease in the fair value of its investment into Canopy was also recognized during the latest quarter for the alcohol maker.

Shares of Constellation dropped after the earnings report was released last week, falling 8.2 percent from a high of US$208.14 on Wednesday (October 2) to a low of US$191.02 on Thursday.

Constellation closed the trading day on Monday (October 7) at US$188.74.

Canopy Growth shares fared a bit better last week with a bit of fluctuation in New York from a high on Wednesday of US$22.58 to a low of US$21.52 on Thursday, a 4.7 percent decrease in value. Canopy was at US$22.23 at market close on Monday.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less